is saxenda a glp 1 medication (Liraglutide) FDA Approves First Generic GLP-1

In retatrutides TRIUMPH-1 trial, the highest-dose group reported nausea in 42.4% of participants, diarrhea in 32.0%, constipation in 26.1%, and vomiting in 25.3% a higher overall GI burden, which tracks with retatrutides larger effect size and third receptor target

Subtle volume is almost always the right starting point, regardless of the eventual desired volume

Appetite regulation, insulin resistance, stress, sleep, medications, hormones, inflammation, and metabolic adaptation can all make weight loss difficult

More information exist about GLP-1 analogs (as exendine-4) and their efficacy in controlling the evolution of NAFLD

P.IshikawaM.CaligiuriS